-
1
-
-
0033604577
-
Signaling by distinct classes of phosphoinositide 3-kinases
-
COI: 1:CAS:528:DyaK1MXnsF2it7Y%3D, PID: 10579926
-
Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 1999;253:239–54.
-
(1999)
Exp Cell Res
, vol.253
, pp. 239-254
-
-
Vanhaesebroeck, B.1
Waterfield, M.D.2
-
2
-
-
0032497832
-
Structure and function of phosphoinositide 3-kinases
-
COI: 1:CAS:528:DyaK1cXns1Klur8%3D, PID: 9838078
-
Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1998;1436:127–50.
-
(1998)
Biochim Biophys Acta
, vol.1436
, pp. 127-150
-
-
Wymann, M.P.1
Pirola, L.2
-
3
-
-
38149120449
-
Targeting phosphoinositide 3-kinase: moving towards therapy
-
COI: 1:CAS:528:DC%2BD1cXptlerug%3D%3D, PID: 17997386
-
Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta. 2008;1784:159–85.
-
(2008)
Biochim Biophys Acta
, vol.1784
, pp. 159-185
-
-
Marone, R.1
Cmiljanovic, V.2
Giese, B.3
Wymann, M.P.4
-
4
-
-
34250704713
-
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
-
COI: 1:CAS:528:DC%2BD2sXlvVSgsr8%3D, PID: 17362206
-
Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Gronning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N, Shepherd PR. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J. 2007;404:449–58.
-
(2007)
Biochem J
, vol.404
, pp. 449-458
-
-
Chaussade, C.1
Rewcastle, G.W.2
Kendall, J.D.3
Denny, W.A.4
Cho, K.5
Gronning, L.M.6
Chong, M.L.7
Anagnostou, S.H.8
Jackson, S.P.9
Daniele, N.10
Shepherd, P.R.11
-
5
-
-
62849114529
-
Regulation of phosphoinositide 3-kinase expression in health and disease
-
COI: 1:CAS:528:DC%2BD1MXjvVOqu7g%3D, PID: 19299143
-
Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci. 2009;34:115–27.
-
(2009)
Trends Biochem Sci
, vol.34
, pp. 115-127
-
-
Kok, K.1
Geering, B.2
Vanhaesebroeck, B.3
-
6
-
-
33744990592
-
Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation
-
COI: 1:CAS:528:DC%2BD28XksleltL0%3D, PID: 16625210
-
Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ, Vanhaesebroeck B. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature. 2006;441:366–70.
-
(2006)
Nature
, vol.441
, pp. 366-370
-
-
Foukas, L.C.1
Claret, M.2
Pearce, W.3
Okkenhaug, K.4
Meek, S.5
Peskett, E.6
Sancho, S.7
Smith, A.J.8
Withers, D.J.9
Vanhaesebroeck, B.10
-
7
-
-
0037047590
-
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice
-
COI: 1:CAS:528:DC%2BD38Xmt1Cktb4%3D, PID: 12130661
-
Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJ, Vanhaesebroeck B. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science. 2002;297:1031–4.
-
(2002)
Science
, vol.297
, pp. 1031-1034
-
-
Okkenhaug, K.1
Bilancio, A.2
Farjot, G.3
Priddle, H.4
Sancho, S.5
Peskett, E.6
Pearce, W.7
Meek, S.E.8
Salpekar, A.9
Waterfield, M.D.10
Smith, A.J.11
Vanhaesebroeck, B.12
-
8
-
-
84859435368
-
PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model
-
PID: 21384093
-
Kampe M, Lampinen M, Stolt I, Janson C, Stalenheim G, Carlson M. PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model. Inflammation. 2012;35:230–9.
-
(2012)
Inflammation
, vol.35
, pp. 230-239
-
-
Kampe, M.1
Lampinen, M.2
Stolt, I.3
Janson, C.4
Stalenheim, G.5
Carlson, M.6
-
9
-
-
33746581368
-
Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma
-
COI: 1:CAS:528:DC%2BD28Xot1Wrsbg%3D, PID: 16890765
-
Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Puri KD, Lee YC. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol. 2006;118:403–9.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 403-409
-
-
Lee, K.S.1
Park, S.J.2
Kim, S.R.3
Min, K.H.4
Jin, S.M.5
Puri, K.D.6
Lee, Y.C.7
-
10
-
-
15944425792
-
An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model
-
COI: 1:CAS:528:DC%2BD2MXosFygsg%3D%3D, PID: 15683846
-
Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5:495–502.
-
(2005)
Int Immunopharmacol
, vol.5
, pp. 495-502
-
-
Duan, W.1
Aguinaldo Datiles, A.M.2
Leung, B.P.3
Vlahos, C.J.4
Wong, W.S.5
-
11
-
-
84865012034
-
Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia
-
COI: 1:CAS:528:DC%2BC38XltVyjtr0%3D, PID: 22483603
-
Blunt MD, Ward SG. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. Curr Opin Pharmacol. 2012;12:444–51.
-
(2012)
Curr Opin Pharmacol
, vol.12
, pp. 444-451
-
-
Blunt, M.D.1
Ward, S.G.2
-
12
-
-
84875141045
-
Therapeutic applications of PI3K inhibitors in cardiovascular diseases
-
COI: 1:CAS:528:DC%2BC3sXktVGqu7o%3D, PID: 23495693
-
Ghigo A, Morello F, Perino A, Hirsch E. Therapeutic applications of PI3K inhibitors in cardiovascular diseases. Future Med Chem. 2013;5:479–92.
-
(2013)
Future Med Chem
, vol.5
, pp. 479-492
-
-
Ghigo, A.1
Morello, F.2
Perino, A.3
Hirsch, E.4
-
13
-
-
84859057520
-
PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
-
PID: 22233681
-
Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012;14:e1.
-
(2012)
Expert Rev Mol Med
, vol.14
, pp. 1
-
-
Schultze, S.M.1
Hemmings, B.A.2
Niessen, M.3
Tschopp, O.4
-
14
-
-
4043082729
-
Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing
-
COI: 1:CAS:528:DC%2BD2cXmt1OmurY%3D, PID: 15294934
-
Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol. 2004;173:2236–40.
-
(2004)
J Immunol
, vol.173
, pp. 2236-2240
-
-
Reif, K.1
Okkenhaug, K.2
Sasaki, T.3
Penninger, J.M.4
Vanhaesebroeck, B.5
Cyster, J.G.6
-
15
-
-
79952750885
-
Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae
-
COI: 1:CAS:528:DC%2BC3MXhvFCjs74%3D, PID: 21257963
-
Boyle KB, Gyori D, Sindrilaru A, Scharffetter-Kochanek K, Taylor PR, Mocsai A, Stephens LR, Hawkins PT. Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae. J Immunol. 2011;186:2978–89.
-
(2011)
J Immunol
, vol.186
, pp. 2978-2989
-
-
Boyle, K.B.1
Gyori, D.2
Sindrilaru, A.3
Scharffetter-Kochanek, K.4
Taylor, P.R.5
Mocsai, A.6
Stephens, L.R.7
Hawkins, P.T.8
-
16
-
-
79954517766
-
PI3Kbeta plays a critical role in neutrophil activation by immune complexes
-
PID: 21487106
-
Kulkarni S, Sitaru C, Jakus Z, Anderson KE, Damoulakis G, Davidson K, Hirose M, Juss J, Oxley D, Chessa TA, Ramadani F, Guillou H, Segonds-Pichon A, Fritsch A, Jarvis GE, Okkenhaug K, Ludwig R, Zillikens D, Mocsai A, Vanhaesebroeck B, Stephens LR, Hawkins PT. PI3Kbeta plays a critical role in neutrophil activation by immune complexes. Sci Signal. 2011;4:ra23.
-
(2011)
Sci Signal
, vol.4
, pp. 23
-
-
Kulkarni, S.1
Sitaru, C.2
Jakus, Z.3
Anderson, K.E.4
Damoulakis, G.5
Davidson, K.6
Hirose, M.7
Juss, J.8
Oxley, D.9
Chessa, T.A.10
Ramadani, F.11
Guillou, H.12
Segonds-Pichon, A.13
Fritsch, A.14
Jarvis, G.E.15
Okkenhaug, K.16
Ludwig, R.17
Zillikens, D.18
Mocsai, A.19
Vanhaesebroeck, B.20
Stephens, L.R.21
Hawkins, P.T.22
more..
-
17
-
-
84874301974
-
Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function
-
COI: 1:CAS:528:DC%2BC3sXjtVGlsLs%3D, PID: 23275335
-
So L, Yea SS, Oak JS, Lu M, Manmadhan A, Ke QH, Janes MR, Kessler LV, Kucharski JM, Li LS, Martin MB, Ren P, Jessen KA, Liu Y, Rommel C, Fruman DA. Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function. J Biol Chem. 2013;288:5718–31.
-
(2013)
J Biol Chem
, vol.288
, pp. 5718-5731
-
-
So, L.1
Yea, S.S.2
Oak, J.S.3
Lu, M.4
Manmadhan, A.5
Ke, Q.H.6
Janes, M.R.7
Kessler, L.V.8
Kucharski, J.M.9
Li, L.S.10
Martin, M.B.11
Ren, P.12
Jessen, K.A.13
Liu, Y.14
Rommel, C.15
Fruman, D.A.16
-
18
-
-
77950457187
-
PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans
-
COI: 1:CAS:528:DC%2BC3cXktVSlsbg%3D, PID: 20081091
-
Soond DR, Bjorgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM, Galleway F, Twomey B, Clark J, Gaston JS, Tasken K, Bunyard P, Okkenhaug K. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood. 2010;115:2203–13.
-
(2010)
Blood
, vol.115
, pp. 2203-2213
-
-
Soond, D.R.1
Bjorgo, E.2
Moltu, K.3
Dale, V.Q.4
Patton, D.T.5
Torgersen, K.M.6
Galleway, F.7
Twomey, B.8
Clark, J.9
Gaston, J.S.10
Tasken, K.11
Bunyard, P.12
Okkenhaug, K.13
-
19
-
-
2342483743
-
Phosphoinositide 3-kinase in T cell activation and survival
-
COI: 1:CAS:528:DC%2BD2cXjtVSgu70%3D, PID: 15046602
-
Okkenhaug K, Bilancio A, Emery JL, Vanhaesebroeck B. Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans. 2004;32:332–5.
-
(2004)
Biochem Soc Trans
, vol.32
, pp. 332-335
-
-
Okkenhaug, K.1
Bilancio, A.2
Emery, J.L.3
Vanhaesebroeck, B.4
-
20
-
-
33749515632
-
The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells
-
COI: 1:CAS:528:DC%2BD28XhtVansrvP, PID: 17015696
-
Okkenhaug K, Patton DT, Bilancio A, Garcon F, Rowan WC, Vanhaesebroeck B. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol. 2006;177:5122–8.
-
(2006)
J Immunol
, vol.177
, pp. 5122-5128
-
-
Okkenhaug, K.1
Patton, D.T.2
Bilancio, A.3
Garcon, F.4
Rowan, W.C.5
Vanhaesebroeck, B.6
-
21
-
-
77957201023
-
Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
-
COI: 1:CAS:528:DC%2BC3cXht1KisbbF, PID: 20522708
-
Herman SE, Gordon AL, Wagner AJ, Heerema NA, Zhao W, Flynn JM, Jones J, Andritsos L, Puri KD, Lannutti BJ, Giese NA, Zhang X, Wei L, Byrd JC, Johnson AJ. Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood. 2010;116:2078–88.
-
(2010)
Blood
, vol.116
, pp. 2078-2088
-
-
Herman, S.E.1
Gordon, A.L.2
Wagner, A.J.3
Heerema, N.A.4
Zhao, W.5
Flynn, J.M.6
Jones, J.7
Andritsos, L.8
Puri, K.D.9
Lannutti, B.J.10
Giese, N.A.11
Zhang, X.12
Wei, L.13
Byrd, J.C.14
Johnson, A.J.15
-
22
-
-
77956592891
-
PI3K/p110δ is a novel therapeutic target in multiple myeloma
-
COI: 1:CAS:528:DC%2BC3cXhtF2qsb%2FK, PID: 20505158
-
Ikeda H, Hideshima T, Fulciniti M, Perrone G, Miura N, Yasui H, Okawa Y, Kiziltepe T, Santo L, Vallet S, Cristea D, Calabrese E, Gorgun G, Raje NS, Richardson P, Munshi NC, Lannutti BJ, Puri KD, Giese NA, Anderson KC. PI3K/p110δ is a novel therapeutic target in multiple myeloma. Blood. 2010;116:1460–8.
-
(2010)
Blood
, vol.116
, pp. 1460-1468
-
-
Ikeda, H.1
Hideshima, T.2
Fulciniti, M.3
Perrone, G.4
Miura, N.5
Yasui, H.6
Okawa, Y.7
Kiziltepe, T.8
Santo, L.9
Vallet, S.10
Cristea, D.11
Calabrese, E.12
Gorgun, G.13
Raje, N.S.14
Richardson, P.15
Munshi, N.C.16
Lannutti, B.J.17
Puri, K.D.18
Giese, N.A.19
Anderson, K.C.20
more..
-
23
-
-
34250823572
-
Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases
-
COI: 1:CAS:528:DC%2BD2sXmsFCqtr0%3D, PID: 17575152
-
Raynaud FI, Eccles S, Clarke PA, Hayes A, Nutley B, Alix S, Henley A, Di Stefano F, Ahmad Z, Guillard S, Bjerke LM, Kelland L, Valenti M, Patterson L, Gowan S, de Haven BA, Hayakawa M, Kaizawa H, Koizumi T, Ohishi T, Patel S, Saghir N, Parker P, Waterfield M, Workman P. Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 2007;67:5840–50.
-
(2007)
Cancer Res
, vol.67
, pp. 5840-5850
-
-
Raynaud, F.I.1
Eccles, S.2
Clarke, P.A.3
Hayes, A.4
Nutley, B.5
Alix, S.6
Henley, A.7
Di Stefano, F.8
Ahmad, Z.9
Guillard, S.10
Bjerke, L.M.11
Kelland, L.12
Valenti, M.13
Patterson, L.14
Gowan, S.15
de Haven, B.A.16
Hayakawa, M.17
Kaizawa, H.18
Koizumi, T.19
Ohishi, T.20
Patel, S.21
Saghir, N.22
Parker, P.23
Waterfield, M.24
Workman, P.25
more..
-
24
-
-
58149295945
-
Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest
-
COI: 1:CAS:528:DC%2BD1MXosVSjug%3D%3D, PID: 19094964
-
Dan S, Yoshimi H, Okamura M, Mukai Y, Yamori T. Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest. Biochem Biophys Res Commun. 2009;379:104–9.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 104-109
-
-
Dan, S.1
Yoshimi, H.2
Okamura, M.3
Mukai, Y.4
Yamori, T.5
-
25
-
-
34548596728
-
A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma
-
COI: 1:CAS:528:DC%2BD2sXpvFKjtrg%3D, PID: 17804702
-
Fan QW, Cheng CK, Nicolaides TP, Hackett CS, Knight ZA, Shokat KM, Weiss WA. A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. Cancer Res. 2007;67:7960–5.
-
(2007)
Cancer Res
, vol.67
, pp. 7960-7965
-
-
Fan, Q.W.1
Cheng, C.K.2
Nicolaides, T.P.3
Hackett, C.S.4
Knight, Z.A.5
Shokat, K.M.6
Weiss, W.A.7
-
26
-
-
17644365138
-
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
-
COI: 1:CAS:528:DC%2BD2MXktFOjtbg%3D, PID: 15771568
-
Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol. 2005;23:127–59.
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 127-159
-
-
Cyster, J.G.1
-
27
-
-
33748160137
-
T-cell homing specificity and plasticity: new concepts and future challenges
-
COI: 1:CAS:528:DC%2BD28XktVyit7w%3D, PID: 16580261
-
Mora JR, von Andrian UH. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006;27:235–43.
-
(2006)
Trends Immunol
, vol.27
, pp. 235-243
-
-
Mora, J.R.1
von Andrian, U.H.2
-
28
-
-
2142730100
-
Central memory and effector memory T cell subsets: function, generation, and maintenance
-
COI: 1:CAS:528:DC%2BD2cXktlOgsb8%3D, PID: 15032595
-
Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–63.
-
(2004)
Annu Rev Immunol
, vol.22
, pp. 745-763
-
-
Sallusto, F.1
Geginat, J.2
Lanzavecchia, A.3
-
29
-
-
0031571264
-
Mechanisms of L-selectin regulation by activated T cells
-
COI: 1:CAS:528:DyaK2sXltlCmur4%3D, PID: 9257829
-
Chao CC, Jensen R, Dailey MO. Mechanisms of L-selectin regulation by activated T cells. J Immunol. 1997;159:1686–94.
-
(1997)
J Immunol
, vol.159
, pp. 1686-1694
-
-
Chao, C.C.1
Jensen, R.2
Dailey, M.O.3
-
30
-
-
42649086026
-
CCR7 and its ligands: balancing immunity and tolerance
-
PID: 18379575
-
Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8:362–71.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 362-371
-
-
Forster, R.1
Davalos-Misslitz, A.C.2
Rot, A.3
-
31
-
-
33749169817
-
Specificity and plasticity of memory lymphocyte migration
-
COI: 1:CAS:528:DC%2BD28XpvFeltrY%3D, PID: 16922087
-
Mora JR, von Andrian UH. Specificity and plasticity of memory lymphocyte migration. Curr Top Microbiol Immunol. 2006;308:83–116.
-
(2006)
Curr Top Microbiol Immunol
, vol.308
, pp. 83-116
-
-
Mora, J.R.1
von Andrian, U.H.2
-
32
-
-
42449110816
-
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
-
COI: 1:CAS:528:DC%2BD1cXkvVOqtb0%3D, PID: 18391955
-
Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, Ager A, Okkenhaug K, Hagenbeek TJ, Spits H, Cantrell DA. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol. 2008;9:513–21.
-
(2008)
Nat Immunol
, vol.9
, pp. 513-521
-
-
Sinclair, L.V.1
Finlay, D.2
Feijoo, C.3
Cornish, G.H.4
Gray, A.5
Ager, A.6
Okkenhaug, K.7
Hagenbeek, T.J.8
Spits, H.9
Cantrell, D.A.10
-
33
-
-
35148819807
-
PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA
-
COI: 1:CAS:528:DC%2BD2sXhtFKitrrL, PID: 17900864
-
Smith LD, Hickman ES, Parry RV, Westwick J, Ward SG. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell Signal. 2007;19:2528–39.
-
(2007)
Cell Signal
, vol.19
, pp. 2528-2539
-
-
Smith, L.D.1
Hickman, E.S.2
Parry, R.V.3
Westwick, J.4
Ward, S.G.5
-
34
-
-
77951678634
-
The role of mTOR in memory CD8 T-cell differentiation
-
COI: 1:CAS:528:DC%2BC3cXnt1Kjtrc%3D, PID: 20536567
-
Araki K, Youngblood B, Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev. 2010;235:234–43.
-
(2010)
Immunol Rev
, vol.235
, pp. 234-243
-
-
Araki, K.1
Youngblood, B.2
Ahmed, R.3
-
35
-
-
79151486083
-
Metabolism, migration and memory in cytotoxic T cells
-
COI: 1:CAS:528:DC%2BC3MXlsFegtA%3D%3D, PID: 21233853
-
Finlay D, Cantrell DA. Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol. 2011;11:109–17.
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 109-117
-
-
Finlay, D.1
Cantrell, D.A.2
-
36
-
-
0030019716
-
Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production
-
COI: 1:CAS:528:DyaK28XnslCisQ%3D%3D, PID: 8558072
-
Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol. 1996;59:81–9.
-
(1996)
J Leukoc Biol
, vol.59
, pp. 81-89
-
-
Taub, D.D.1
Ortaldo, J.R.2
Turcovski-Corrales, S.M.3
Key, M.L.4
Longo, D.L.5
Murphy, W.J.6
-
37
-
-
84868103203
-
Poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation
-
COI: 1:CAS:528:DC%2BC38XhsFSmtrvP, PID: 22750548
-
Meyer T, Oberg HH, Peters C, Martens I, Adam-Klages S, Kabelitz D, Wesch D. Poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation. J Leukoc Biol. 2012;92:765–74.
-
(2012)
J Leukoc Biol
, vol.92
, pp. 765-774
-
-
Meyer, T.1
Oberg, H.H.2
Peters, C.3
Martens, I.4
Adam-Klages, S.5
Kabelitz, D.6
Wesch, D.7
-
38
-
-
0032829555
-
The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro
-
COI: 1:CAS:528:DyaK1MXmslGruro%3D, PID: 10516042
-
Creson JR, Lin AA, Li Q, Broad DF, Roberts MR, Anderson SJ. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. J Virol. 1999;73:9337–47.
-
(1999)
J Virol
, vol.73
, pp. 9337-9347
-
-
Creson, J.R.1
Lin, A.A.2
Li, Q.3
Broad, D.F.4
Roberts, M.R.5
Anderson, S.J.6
-
39
-
-
79958696667
-
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kgamma, a single convergent point promoting tumor inflammation and progression
-
COI: 1:CAS:528:DC%2BC3MXnsVClu70%3D, PID: 21665146
-
Schmid MC, Avraamides CJ, Dippold HC, Franco I, Foubert P, Ellies LG, Acevedo LM, Manglicmot JR, Song X, Wrasidlo W, Blair SL, Ginsberg MH, Cheresh DA, Hirsch E, Field SJ, Varner JA. Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kgamma, a single convergent point promoting tumor inflammation and progression. Cancer Cell. 2011;19:715–27.
-
(2011)
Cancer Cell
, vol.19
, pp. 715-727
-
-
Schmid, M.C.1
Avraamides, C.J.2
Dippold, H.C.3
Franco, I.4
Foubert, P.5
Ellies, L.G.6
Acevedo, L.M.7
Manglicmot, J.R.8
Song, X.9
Wrasidlo, W.10
Blair, S.L.11
Ginsberg, M.H.12
Cheresh, D.A.13
Hirsch, E.14
Field, S.J.15
Varner, J.A.16
-
40
-
-
33845379986
-
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+regulatory T cells of both healthy subjects and type 1 diabetic patients
-
COI: 1:CAS:528:DC%2BD28Xht1KisbbJ, PID: 17142730
-
Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 2006;177:8338–47.
-
(2006)
J Immunol
, vol.177
, pp. 8338-8347
-
-
Battaglia, M.1
Stabilini, A.2
Migliavacca, B.3
Horejs-Hoeck, J.4
Kaupper, T.5
Roncarolo, M.G.6
-
41
-
-
84856558003
-
Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-gamma+IL-17+polyfunctional T cells that mediate rejection of murine tumors
-
COI: 1:CAS:528:DC%2BC38XhslCjsb8%3D, PID: 22158905
-
Marshall NA, Galvin KC, Corcoran AM, Boon L, Higgs R, Mills KH. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-gamma+IL-17+polyfunctional T cells that mediate rejection of murine tumors. Cancer Res. 2012;72:581–91.
-
(2012)
Cancer Res
, vol.72
, pp. 581-591
-
-
Marshall, N.A.1
Galvin, K.C.2
Corcoran, A.M.3
Boon, L.4
Higgs, R.5
Mills, K.H.6
|